ReviewESC heart failure2026
Strain imaging in heart failure: from early detection to prognostic assessment.
Review in ESC heart failure, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Traditional left ventricle ejection fraction (LVEF)-centric approaches often detect cardiac dysfunction late and offer limited insights into myocardial mechanics. Myocardial strain imaging by two-dimensional speckle-tracking echocardiography has emerged as a high-sensitivity alternative for comprehensive evaluation of heart failure (HF). This synthesis evaluates the diagnostic, prognostic, and therapeutic monitoring capabilities of multi-chamber strain imaging across the HF spectrum. Based on current evidence, global longitudinal strain (GLS) provides superior sensitivity over LVEF in detecting subclinical myocardial injury. In preclinical settings (Stage B HF), a GLS <16% is an important diagnostic criterion, reclassifying 13% of asymptomatic patients and predicting a four-fold higher risk of HF hospitalization. In cardio-oncology, a 15% relative decline in GLS successfully identifies subclinical toxicity before LVEF drops. Across HF phenotypes, GLS <16% has been incorporated as a minor diagnostic criterion for heart failure with preserved ejection fraction (HFpEF). GLS is a 1.6-fold better prognostic marker than LVEF (particularly in preclinical stages and HFpEF) and exhibits a more linear relationship with mortality. Furthermore, left atrial reservoir strain (<18%) accurately grades diastolic dysfunction, while right ventricular free-wall longitudinal strain acts as a powerful independent predictor of death. In conclusion, strain imaging has expanded from a specialized technique to a part of contemporary HF evaluation. By capturing myocardial mechanics, it enables early detection, precise phenotyping, robust risk stratification, and timely therapy monitoring.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.